LL-01 THE RELATIONSHIP BETWEEN B2M AND CNS LYMPHOMA

Por Ghiaseddin, Ashley, Snook, Riley
Publicado em 2014

Use of bevacizumab in recurrent glioblastoma

Por Ghiaseddin, Ashley, Peters, Katherine B
Publicado no CNS Oncol (2015)

ACTR-60. A PHASE 2, HISTORICALLY CONTROLLED STUDY TESTING THE EFFICACY OF TTFIELDS WITH ADJUVANT TEMOZOLOMIDE IN HIGH-RISK WHO GRADE II AND III ASTROCYTOMAS (FORWARD)

Por Tran, David, Ghiaseddin, Ashley, Allen, Anne
Publicado no Neuro Oncol (2019)

Tumor Treating Fields in the Management of Patients with Malignant Gliomas

Por Ghiaseddin, Ashley P., Shin, David, Melnick, Kaitlyn, Tran, David D.
Publicado no Curr Treat Options Oncol (2020)

CTIM-29. CRUCIAL APPLICATION OF SINGLE CELL GENE EXPRESSION FOR MONITORING CHANGES IN GLIOBLASTOMA PATIENTS WITH SUSTAINED RADIOGRAPHIC RESPONSE TO CMV pp65-LAMP RNA-PULSED DENDRIT...

Por Yegorov, Oleg, Yang, Changlin, Dechkovskaia, Anjelika, Rahman, Maryam, Ghiaseddin, Ashley, Mitchell, Duane
Publicado no Neuro Oncol (2020)

ATIM-17. EARLY RESULTS OF A MULTICENTER PHASE I AND OPEN-LABEL, RANDOMIZED PHASE II STUDY TESTING THE TOXICITIES AND EFFICACY OF MK-3475 (PEMBROLIZUMAB) IN COMBINATION WITH MRI-GUI...

Por Campian, Jian, Ghiaseddin, Ashley, Rahman, Maryam, Ansstas, George, Kim, Albert, Leuthardt, Eric, Tran, David
Publicado no Neuro Oncol (2017)

ACTR-29. A PHASE 2 STUDY OF TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA

Por Tran, David, Ghiaseddin, Ashley, Campian, Jian, Staal, Stephen, Andrews, Sarah, Warren, Sonisha, Ansstas, George
Publicado no Neuro Oncol (2017)

ATIM-45. LONG TERM FOLLOW-UP OF A PHASE I/II STUDY TESTING THE TOXICITIES AND EFFICACY OF PEMBROLIZUMAB IN COMBINATION WITH MRI-GUIDED LASER INTERSTITIAL THERMAL THERAPY (LITT) IN...

Por Campian, Jian, Ghiaseddin, Ashley, Rahman, Maryam, Huang, Jiayi, Ansstas, George, Kim, Albert, Leuthardt, Eric, Tran, David
Publicado no Neuro Oncol (2019)

ATIM-03. TTFIELDS AND PULSED BEVACIZUMAB IN PATIENTS WITH BEVACIZUMAB-REFRACTORY RECURRENT GLIOBLASTOMA: A PHASE 2 STUDY

Por Tran, David, Ghiaseddin, Ashley, Campian, Jian, Staal, Stephen, Warren, Sonisha, Allen, Anne, Sampson, Deborah, Greene, Valerie, Ansstas, George
Publicado no Neuro Oncol (2018)

ATIM-15. SUSTAINED COMPLETE RADIOGRAPHIC RESPONSE AND PROLONGED SYSTEMIC IMMUNE ACTIVATION IN A PATIENT WITH MGMT UNMETHYLATED MIDLINE GLIOBLASTOMA RECEIVING CMV pp65-LAMP RNA-PULS...

Por Rahman, Maryam, Ghiaseddin, Ashley, Yegorov, Oleg, Yang, Changlin, Dechkovskaia, Anjelika, Tran, David, Massini, Tara, Kresak, Jesse, Mitchell, Duane
Publicado no Neuro Oncol (2019)

ATIM-39. PHASE 2 OPEN-LABELED STUDY OF ADJUVANT TEMOZOLOMIDE PLUS TUMOR TREATING FIELDS PLUS PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)

Por Tran, David, Warren, Sonisha, Allen, Anne, Sampson, Deborah, Chen, Dongjiang, Thomas, Nagheme, Greene, Valerie, Rahman, Maryam, Ghiaseddin, Ashley
Publicado no Neuro Oncol (2019)

CTIM-04. UPDATES FOR A PHASE 2 OPEN-LABELED STUDY OF PEMBROLIZUMAB PLUS TTFIELDS PLUS MAINTENANCE TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)

Por Ghiaseddin, Ashley, Warren, Sonisha, Allen, Annie, Sampson, Deborah, Chen, Dongjiang, Sherman, Alexandra, Greene, Valerie, Rahman, Maryam, Tran, David
Publicado no Neuro Oncol (2020)

IMMU-42. DUAL ACTIVATION OF THE cGAS-STING PATHWAY AND AIM2-INDUCED PYROPTOSIS BY TUMOR-TREATING FIELDS PRODUCES ANTI-TUMOR IMMUNITY IN GLIOBLASTOMA

Por Chen, Dongjiang, Sebastian, Mathew, Hutchinson, Tarun, Ghiaseddin, Ashley, Warren, Sonisha, Allen, Annie, Jin, Dan, Le, Son, Tran, David
Publicado no Neuro Oncol (2020)

Intracranial myxoid mesenchymal neoplasms with EWSR1 gene rearrangement: report of 2 midline cases with one demonstrating durable response to MET inhibitor monotherapy

Por De Los Santos, Yanel, Shin, David, Malnik, Samuel, Rivera-Zengotita, Marie, Tran, David, Ghiaseddin, Ashley, Lee Kresak, Jesse
Publicado no Neurooncol Adv (2021)

Introducing a Supportive Care Team for Advance Directive Education in a Neurological and Neurosurgical Patient Population

Por Henke, Charlotte, Mroz, Emily, Le, Ngoc Anh, Gregory, Hannah M, Ghiaseddin, Ashley, McFarland, Nikolaus R, Baron-Lee, Jacqueline
Publicado no J Patient Exp (2020)

PATH-27. IDENTIFYING THE GENETIC SIGNATURE OF RESPONSE IN A PHASE II STUDY OF TUMOR TREATING FIELDS IN RECURRENT GLIOBLASTOMA

Por Tran, David, Warren, Sonisha, Friedman, William, Ghiaseddin, Ashley, Murad, Gregory, Rahman, Maryam, Roper, Steven, Allen, Anne, Greene, Valerie, Yachnis, Anthony
Publicado no Neuro Oncol (2018)

AT-22 PHASE II TRIAL OF BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION

Por Ghiaseddin, Ashley, Dunn-Pirio, Anastasie, Peters, Katherine, Vlahovic, Gordana, Herndon, James, Threatt, Stevie, Sampson, John, Friedman, Allan, Friedman, Henry, Desjardins, Annick
Publicado em 2014

Adult precision medicine: learning from the past to enhance the future

Por Ghiaseddin, Ashley, Hoang Minh, Lan B, Janiszewska, Michalina, Shin, David, Wick, Wolfgang, Mitchell, Duane A, Wen, Patrick Y, Grossman, Stuart A
Publicado no Neurooncol Adv (2020)

ATIM-34. SINGLE-CELL RNA SEQUENCING REVEALS DYNAMIC IMMUNE RESPONSE CHANGES IN GLIOBLASTOMA PATIENT WITH DURABLE COMPLETE RESPONSE TO CMV PP65-LAMP RNA-PULSED DENDRITIC VACCINES

Por Yegorov, Oleg, Yang, Changlin, Rahman, Maryam, Ghiaseddin, Ashley, Dechkovskaia, Anjelika, Cleaver, Brian, Hodik, Marcia, Amdur, Robert, Massini, Tara, Kresak, Jesse, Mitchell, Duane
Publicado no Neuro Oncol (2019)

QOL-19 PROSPECTIVE EVALUATION OF CARDIOPULMONARY FITNESS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING AN ANTI-ANGIOGENIC REGIMEN

Por Ghiaseddin, Ashley, West, Miranda, Hornsby, Whitney, Freeman, Maria, Lipp, Eric, McSherry, Frances, Herndon, James, Desjardins, Annick, Friedman, Henry, Jones, Lee, Peters, Katherine
Publicado no Neuro Oncol (2015)